← Back to Clinical Trials
Recruiting NCT07276061

NCT07276061 Outpatient Total Knee Arthroscopy (TKA): Comparison of Postoperative Recovery Versus a Conventional Hospitalization

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07276061
Status Recruiting
Phase
Sponsor University Hospital, Strasbourg, France
Condition Knee Arthroscopy
Study Type OBSERVATIONAL
Enrollment 440 participants
Start Date 2024-03-11
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 440 participants in total. It began in 2024-03-11 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Outpatient TKA is a controversial topic due to concerns about its safety as an outpatient procedure, and remains a marginal procedure. Advances in enhanced postoperative rehabilitation protocols, coupled with advances in minimally invasive surgery, have made it possible to operate on an increasing number of patients on an outpatient basis. However, there are no studies in the literature analyzing functional recovery after outpatient TKA in France. The objective of this study was to compare postoperative recovery, assessed by the QoR-15F score, in patients undergoing outpatient TKA compared to those undergoing a conventional hospitalization.

Eligibility Criteria

Inclusion Criteria: * Male or female, 18 years of age or older (no upper age limit) * Undergoing scheduled unilateral total knee replacement surgery between January 1, 2020 and June 30, 2023 at the Strasbourg University Hospitals * Assessed using the QoR-15F score Exclusion Criteria: * Subject who has expressed opposition to the reuse of their data for scientific research purposes. * Revision, emergency, oncological, bilateral, or septic surgery.

Contact & Investigator

Central Contact

Eric NOLL, MD, PhD

✉ eric.noll@chru-strasbourg.fr

📞 33 3 88 12 70 76

Frequently Asked Questions

Who can join the NCT07276061 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Arthroscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07276061 currently recruiting?

Yes, NCT07276061 is actively recruiting participants. Contact the research team at eric.noll@chru-strasbourg.fr for enrollment information.

Where is the NCT07276061 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07276061 clinical trial?

NCT07276061 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 440 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology